Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine-Reference-Cited by-同舟云学术

Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine

Published:2020-01 Issue: Volume:78 Page:106013
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Zhou Ya,Li Shuxiang,Bi Shuai,Li Ning,Bi Yuhai,Liu Wenjun,Wang Beinan

Funder

Chinese National Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference47 articles.

1. FAO, H7N9 situation update, 2019. .

2. Continuing challenges in influenza;Webster;Ann. NY Acad. Sci.,2014

3. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design;De Groot;Hum. Vaccin. Immunother.,2013

4. Influenza A(H7N9) virus antibody responses in survivors 1 year after infection, China, 2017;Ma;Emerg. Infect. Dis.,2018

5. Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines;He;J. Gen. Virol.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-based pulmonary particulate systems for anticancer and antiviral drug carriers: A promising delivery for COVID-19 vaccines;Results in Chemistry;2023-12

2. Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract;Microbiology Spectrum;2022-02-23

3. A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID‐19;Journal of Applied Microbiology;2021-07-26

4. Existing Developments in Adaptive Smart Grid Protection: A Review;Electric Power Systems Research;2021-02

5. Progress in the Development of Universal Influenza Vaccines;Viruses;2020-09-17